Inflammatory Bowel Disease and Pregnancy

Eugenia Shmidt, Marla C. Dubinsky

Research output: Contribution to journalArticlepeer-review

9 Scopus citations
Original languageEnglish (US)
Pages (from-to)S60-S68
JournalAmerican Journal of Gastroenterology
Issue number10S
StatePublished - Oct 1 2022

Bibliographical note

Funding Information:
Financial support: This article appeared as part of the ACG Monograph on GI Diseases and Endoscopy in Pregnancy and Postpartum Period. Unrestricted educational grants to support the monograph have been provided to the ACG Institute for Clinical Research and Education from UCB, Inc., Ferring Pharmaceuticals, Inc., and Janssen Biotech, Inc.

Funding Information:
Potential competing interests: M.C.D. is a consultant for Abbvie, Arena, Bristol Myers Squibb, Janssen, Lilly, Pfizer, Prometheus Biosciences, Takeda. Shareholder and Employer Trellus Health. E.S. has received research funding from Bristol Byers Squibb, UCB. E.S. has no disclosures.


  • Female
  • Humans
  • Inflammatory Bowel Diseases/diagnosis
  • Pregnancy
  • Pregnancy Complications/therapy
  • Pregnancy Outcome

PubMed: MeSH publication types

  • Journal Article

Cite this